Integral Diagnostics Limited (IDX.AX)
AUD 2.17
(1.4%)
AUD 2.17
(1.4%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 442.56 Million AUD | -5.02% |
| 2023 | 465.96 Million AUD | 6.93% |
| 2022 | 435.77 Million AUD | 8.9% |
| 2021 | 400.16 Million AUD | 11.6% |
| 2020 | 358.58 Million AUD | 91.3% |
| 2019 | 187.44 Million AUD | 83.57% |
| 2018 | 102.11 Million AUD | 2.08% |
| 2017 | 100.03 Million AUD | 2.93% |
| 2016 | 97.18 Million AUD | 6.68% |
| 2015 | 91.1 Million AUD | 1605.99% |
| 2014 | 5.34 Million AUD | 4854461.82% |
| 2013 | 110.00 AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 442.56 Million AUD | -5.02% |
| 2024 Q2 | 445.42 Million AUD | -4.41% |
| 2024 Q4 | 442.56 Million AUD | -0.64% |
| 2023 Q2 | 468.64 Million AUD | 7.54% |
| 2023 FY | 465.96 Million AUD | 6.93% |
| 2023 Q4 | 465.96 Million AUD | -0.57% |
| 2022 FY | 435.77 Million AUD | 8.9% |
| 2022 Q2 | 449.6 Million AUD | 12.36% |
| 2022 Q4 | 435.77 Million AUD | -3.08% |
| 2021 Q2 | 402.48 Million AUD | 14.3% |
| 2021 Q4 | 400.16 Million AUD | -0.58% |
| 2021 FY | 400.16 Million AUD | 11.6% |
| 2020 Q4 | 352.13 Million AUD | 8.66% |
| 2020 FY | 358.58 Million AUD | 91.3% |
| 2020 Q2 | 324.06 Million AUD | 72.88% |
| 2019 Q2 | 186.15 Million AUD | 82.31% |
| 2019 Q4 | 187.44 Million AUD | 0.69% |
| 2019 FY | 187.44 Million AUD | 83.57% |
| 2018 Q2 | 98.58 Million AUD | -1.45% |
| 2018 FY | 102.11 Million AUD | 2.08% |
| 2018 Q4 | 102.11 Million AUD | 3.58% |
| 2017 Q2 | 102.57 Million AUD | 5.55% |
| 2017 Q4 | 100.03 Million AUD | -2.48% |
| 2017 FY | 100.03 Million AUD | 2.93% |
| 2016 Q4 | 97.18 Million AUD | 4.81% |
| 2016 Q2 | 92.72 Million AUD | -18.8% |
| 2016 FY | 97.18 Million AUD | 6.68% |
| 2015 Q4 | 114.19 Million AUD | 0.0% |
| 2015 FY | 91.1 Million AUD | 1605.99% |
| 2014 FY | 5.34 Million AUD | 4854461.82% |
| 2013 FY | 110.00 AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Australian Clinical Labs Limited | 415.29 Million AUD | -6.567% |
| BCAL Diagnostics Limited | 3.67 Million AUD | -11935.551% |
| Genetic Signatures Limited | 6.18 Million AUD | -7056.679% |
| Genetic Technologies Limited | 4.35 Million AUD | -10059.739% |
| Healius Limited | 1.94 Billion AUD | 77.212% |
| Imagion Biosystems Limited | 8.37 Million AUD | -5184.836% |
| INOVIQ Ltd | 1.71 Million AUD | -25640.109% |
| Microba Life Sciences Limited | 16.82 Million AUD | -2530.534% |
| Monash IVF Group Limited | 261.81 Million AUD | -69.041% |
| Rhythm Biosciences Limited | 651.54 Thousand AUD | -67826.396% |
| Sonic Healthcare Limited | 6.75 Billion AUD | 93.445% |